American Century Companies’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,991
Closed -$138K 2933
2023
Q4
$138K Buy
4,991
+2,777
+125% +$169K ﹤0.01% 2764
2023
Q3
$135K Buy
2,214
+688
+45% +$48.3K ﹤0.01% 2676
2023
Q2
$100K Buy
1,526
+786
+106% +$57.5K ﹤0.01% 2677
2023
Q1
$46.5K Sell
740
-285
-28% -$32.5K ﹤0.01% 2631
2022
Q4
$142K Buy
+1,025
New +$144K ﹤0.01% 2398
2020
Q4
Sell
-13,603
Closed -$9.51M 1970
2020
Q3
$9.51M Buy
13,603
+13
+0.1% +$10.1K 0.01% 719
2020
Q2
$10.7M Buy
13,590
+7
+0.1% +$5.28K 0.01% 659
2020
Q1
$8.09M Sell
13,583
-25,029
-65% -$24.4M 0.01% 639
2019
Q4
$43.9M Buy
38,612
+2,906
+8% +$3.16M 0.04% 369
2019
Q3
$42.5M Sell
35,706
-4,651
-12% -$7.1M 0.04% 363
2019
Q2
$66.5M Buy
40,357
+3,089
+8% +$5.34M 0.07% 312
2019
Q1
$76M Buy
37,268
+2,195
+6% +$3.87M 0.08% 294
2018
Q4
$45.1M Buy
35,073
+10,208
+41% +$15.7M 0.05% 357
2018
Q3
$47M Buy
24,865
+10,017
+67% +$20.7M 0.05% 360
2018
Q2
$30.2M Sell
14,848
-86
-0.6% -$196K 0.03% 448
2018
Q1
$33M Sell
14,934
-3,148
-17% -$8.01M 0.03% 421
2017
Q4
$41.7M Buy
18,082
+563
+3% +$1.14M 0.04% 410
2017
Q3
$31.2M Buy
+17,519
New +$24.5M 0.03% 441
2017
Q1
Sell
-933
Closed -$746K 1313
2016
Q4
$746K Sell
933
-481
-34% -$382K ﹤0.01% 1188
2016
Q3
$1.24M Buy
+1,414
New +$1.02M ﹤0.01% 1130
2016
Q1
Sell
-318
Closed -$265K 1300
2015
Q4
$265K Sell
318
-10,142
-97% -$10.1M ﹤0.01% 1265
2015
Q3
$11.6M Buy
10,460
+612
+6% +$1.12M 0.01% 615
2015
Q2
$21.5M Buy
9,848
+8,459
+609% +$17.2M 0.02% 536
2015
Q1
$2.17M Sell
1,389
-54
-4% -$71.2K ﹤0.01% 1032
2014
Q4
$1.72M Buy
+1,443
New +$964K ﹤0.01% 1114

Other funds holding BLUE

American Century Companies's BLUE Position: Q1 2024 in Review

American Century Companies sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 4,991 shares — an estimated $138K sold.

American Century Companies first reported a position in BLUE in Q4 2014 and held it in 25 quarters. The position peaked at $76M in Q1 2019. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • American Century Companies reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • American Century Companies sold 4,991 bluebird bio shares in Q1 2024, an estimated $138K.
  • American Century Companies first reported a position in bluebird bio in Q4 2014 and held it in 25 quarters.
  • American Century Companies's bluebird bio position peaked at $76M in Q1 2019.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.